プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
comparison between formulations
samanburður á töfluformum
最終更新: 2017-04-26
使用頻度: 1
品質:
tmax was similar with both formulations.
hámarkstími (tmax) var svipaður hjá báðum lyfjaformunum.
最終更新: 2017-04-26
使用頻度: 1
品質:
description of available deferasirox formulations
lýsingu á fáanlegum lyfjaformum deferasirox
最終更新: 2017-04-26
使用頻度: 1
品質:
switching from other formulations of guanfacine
skipt úr öðrum lyfjaformum gúanfacíns
最終更新: 2017-04-26
使用頻度: 1
品質:
undesirable effects noted with risperidone formulations
aukaverkanir sem hafa komið fram við notkun risperidon lyfjaforma
最終更新: 2017-04-26
使用頻度: 1
品質:
comparable skin tolerability was reported for both formulations.
báðar samsetningarnar þoldust álíka vel.
最終更新: 2017-04-26
使用頻度: 1
品質:
conversion between modigraf and prograf tacrolimus formulations
skipting á milli takrólímus lyfjaforma modigraf og prograf
最終更新: 2017-04-26
使用頻度: 1
品質:
time to maximum concentration was also similar between formulations.
tíminn þar til hámarksstyrk var náð var einnig sá sami hjá báðum lyfjaformum.
最終更新: 2017-04-26
使用頻度: 1
品質:
do not use interchangeably with other formulations of doxorubicin hydrochloride.
notiÐ ekki Í staÐinn fyrir aÐra tegund af doxÓrÚbicÍn hÝdrÓklÓrÍÐi.
最終更新: 2017-04-26
使用頻度: 1
品質:
when transitioning between formulations, a change in dose may be needed.
Þegar skipt er á milli lyfjaforma getur þurft að breyta skammti.
最終更新: 2017-04-26
使用頻度: 1
品質:
education about the 2 intramuscular formulations of olanzapine, including packaging differences
fræðslu um tvö lyfjaform olanzapins til notkunar í vöðva, þar með talið mismunur á pakkningum
最終更新: 2017-04-26
使用頻度: 1
品質:
in the first study, all 153 premature infants received both formulations in different sequences.
Í fyrri rannsókninni fengu 153 fyrirburar bæði lyfjaformin í mismunandi röð.
最終更新: 2017-04-26
使用頻度: 1
品質:
bimatoprost 0.3 mg/ml (multi-dose and single-dose formulations)
bimatoprost 0,3 mg/ml (fjölskammta- og stakskammtasamsetningar)
最終更新: 2017-04-26
使用頻度: 1
品質:
medication errors involving mix-up between subcutaneous insuman formulations or other subcutaneous insulins have been reported.
greint hefur verið frá mistökum við lyfjagjöf þar sem önnur insuman lyfjaform eða önnur insúlín hafa fyrir mistök verið gefin.
最終更新: 2017-04-26
使用頻度: 1
品質:
a high dose of a shorter duration intramuscular injection formulation was used.
stór skammtur af lyfjaformi með styttri verkun til inndælingar í vöðva var notaður.
最終更新: 2017-04-26
使用頻度: 1
品質: